Copyright
©The Author(s) 2015.
World J Hepatol. May 28, 2015; 7(9): 1251-1257
Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1251
Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1251
Figure 1 Pathogenic mechanisms of valproic acid-induced nonalcoholic fatty liver disease/nonalcoholic steato-hepatitis.
VPA: Valproic acid; GABA: Gamma-aminobutyric acid; FIAF: Fasting-induced adipose factor; ADIPO-R1: Adiponectin receptor expression; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic steato-hepatitis.
- Citation: Farinelli E, Giampaoli D, Cenciarini A, Cercado E, Verrotti A. Valproic acid and nonalcoholic fatty liver disease: A possible association? World J Hepatol 2015; 7(9): 1251-1257
- URL: https://www.wjgnet.com/1948-5182/full/v7/i9/1251.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i9.1251